EDMONTON, AB, Dec. 13, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to acknowledge the Company's increased ranking in The Globe and Mail's 2021 annual Report on Business review of Corporate Boards, known as Board Games. As recognized in the 2021 Board Games results, Aurora received 77 out of 100 eligible points, ranking notably higher than others in its peer group of cannabis companies.
For the 20th year in a row, Report on Business has assessed the boards and governance practices of Canada's largest corporations within the S&P/TSX Composite using a rigorous set of governance criteria designed to go beyond minimum mandatory rules imposed by regulators. Evaluated across four categories including Board Composition, Shareholding and Compensation, Shareholder Rights, and Disclosure, Aurora's 2021 score signifies a considerable improvement from the previous years' results of 72 and 67 out of 100 in 2020 and 2019, respectively.
Ronald Funk, Chairman of Aurora stated, "With each passing year, Aurora continues to exhibit growth and maturity across all areas of the business. Our improved ranking in the 2021 Board Games report is a strong indication of the progress we are making as an organization as we continue to identify ways in which our policies and practices can better serve our stakeholders. I am proud and honoured to be part of a Board that stands out from its peers and demonstrates strength in governance, strategic direction and accountability."
Aurora's 2021 Proxy Circular can be viewed here. For more information on The Globe and Mail's Board Games methodology and to view this year's comprehensive ranking of Canada's corporate boards, visit here.
About Aurora
Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at https://www.auroramj.com/ and follow us on Twitter and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index.